Eloxx Pharmaceuticals, Inc. · NASDAQ:ELOX
Eloxx Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 20 institutions reported holding Eloxx Pharmaceuticals, Inc., 71.8% of its shares. Largest: Nantahala Capital Management, LLC, EcoR1 Capital, LLC and abrdn. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Eloxx Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 800K | 19.8% | new | Aug 19, 2026 |
| EcoR1 Capital, LLC | 400K | 9.9% | new | Aug 14, 2026 |
| abrdn | 400K | 9.9% | new | Jul 31, 2026 |
| Samsara Biocapital, LLC | 400K | 9.9% | new | Aug 14, 2026 |
| Siren, L.L.C. | 400K | 9.9% | new | Aug 13, 2026 |
| Stonepine Capital Management, LLC | 397K | 9.8% | new | Aug 17, 2026 |
| Vanguard | 90,000 | 2.2% | new | Aug 13, 2026 |
| Seven Grand Managers, LLC | 10,000 | 0.25% | new | Aug 14, 2026 |
| Morgan Stanley | 1,544 | 0.04% | new | Aug 13, 2026 |
| UBS | 637 | 0.02% | new | Aug 13, 2026 |